FDA Approves New Fast-Acting Tylenol With Naproxen for Longer Lasting Pain Relief

The FDA has approved a new over-the-counter Tylenol with naproxen sodium that offers fast pain relief lasting up to 12 hours. Learn how it works, its benefits, safety considerations, and what experts say.

Millions of people rely on over-the-counter pain relievers every day to manage headaches, muscle pain, backaches, arthritis, and menstrual cramps. Now, consumers in the United States will soon have another option after the U.S. Food and Drug Administration (FDA) approved a new formulation that combines Tylenol with naproxen sodium.

The newly approved medication is designed to provide fast, non-opioid pain relief while offering longer-lasting effects than standard acetaminophen products. According to manufacturer Kenvue, the combination tablet begins working in approximately 30 minutes and can provide pain relief for up to 12 hours.

The approval comes at a time when healthcare providers continue to encourage effective alternatives to opioid medications for managing common pain conditions.

What Is the New Tylenol With Naproxen?

The newly approved over-the-counter medication combines two well-known pain-relieving ingredients:

• Acetaminophen (Tylenol), commonly used to reduce pain and fever.
• Naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce inflammation and relieve pain.

Each ingredient works differently inside the body. Acetaminophen primarily targets pain and fever, while naproxen helps reduce inflammation that contributes to many painful conditions.

By combining these medications into one tablet, the manufacturer aims to provide quicker and longer-lasting relief without requiring consumers to alternate between different medications.

What Conditions Can It Treat?

According to Kenvue, the new medication is intended for temporary relief of several common conditions, including:

• Headaches
• Back pain
• Muscle aches
• Toothaches
• Menstrual cramps
• Minor arthritis pain
• Everyday aches and pains

Like other over-the-counter pain medications, it is not intended to treat chronic medical conditions without guidance from a healthcare professional.

How Fast Does It Work?

One of the biggest selling points of the new product is its speed.

Kenvue says users may begin experiencing pain relief within about 30 minutes after taking the medication. The effects may continue for as long as 12 hours, potentially reducing the need for frequent dosing throughout the day.

For people dealing with persistent pain, fewer doses could improve convenience while maintaining symptom relief.

A Non-Opioid Alternative

The approval also reflects growing interest in expanding non-opioid pain management options.

Health officials have spent years encouraging safer pain treatments due to the ongoing opioid addiction crisis. Prescription opioids remain important for treating severe pain, but they also carry significant risks of dependence and misuse.

Kenvue highlighted that its new combination tablet does not contain opioids and therefore avoids the addiction risks associated with opioid medications.

Many healthcare providers recommend trying appropriate non-opioid therapies first for common pain conditions whenever possible.

FDA Grants Market Exclusivity

Alongside the approval, the FDA granted Kenvue a three-year period of market exclusivity for this specific over-the-counter formulation.

Market exclusivity does not prevent other companies from selling acetaminophen or naproxen individually. Instead, it temporarily protects this particular approved combination product from direct competition under the same regulatory pathway.

This gives Kenvue an opportunity to introduce the product nationwide before similar formulations become available.

When Will It Be Available?

Kenvue has announced that the medication will be available in retail stores across the United States soon.

Although the company has confirmed the product's approval, exact launch dates may vary depending on retailers and distribution schedules.

Consumers should also expect availability through pharmacies, supermarkets, and major online retailers once distribution begins.

Pregnancy Safety Debate Continues

The FDA approval arrives amid continued public discussion regarding acetaminophen use during pregnancy.

Some political figures, including President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr., have publicly suggested that taking acetaminophen during pregnancy could increase the risk of autism in children.

However, major medical organizations have stated that existing scientific evidence does not establish a direct cause-and-effect relationship.

The American College of Obstetricians and Gynecologists (ACOG) has emphasized that current research does not support claims that appropriate acetaminophen use during pregnancy causes autism.

Medical experts note that autism is a complex condition influenced by multiple genetic and environmental factors, and no single medication has been proven to be its direct cause.

Pregnant individuals should always consult their healthcare provider before taking any medication, including over-the-counter pain relievers.

What Experts Say

Medical professionals generally agree that combining two established non-opioid medications may provide an additional treatment option for patients seeking effective pain management.

For people with recurring headaches, muscle soreness, or joint discomfort, longer-lasting relief could reduce the need for repeated doses throughout the day.

At the same time, experts remind consumers that even over-the-counter medicines should be used exactly as directed.

Both acetaminophen and NSAIDs have recommended dosage limits, and exceeding them can increase the risk of liver damage, stomach bleeding, kidney problems, or other complications.

Anyone with liver disease, stomach ulcers, kidney disease, heart conditions, or those taking blood-thinning medications should consult a healthcare professional before using products containing naproxen.

What This Means for Consumers

The FDA's approval represents another step toward expanding access to effective non-prescription pain relief options.

As consumers increasingly seek alternatives to opioid medications, combination therapies that provide both fast onset and extended relief may become more popular.

While the new Tylenol with naproxen offers an additional choice for managing everyday pain, selecting the right medication still depends on individual health conditions, current medications, and medical advice.

Reading product labels carefully and following dosing instructions remain essential for safe use.

Final Thoughts

The FDA approval of Tylenol with naproxen sodium introduces a new over-the-counter option that combines two widely used pain relievers into a single tablet. With reported relief beginning in about 30 minutes and lasting up to 12 hours, the medication may appeal to consumers seeking convenient, non-opioid pain management.

Although discussion around acetaminophen safety during pregnancy continues in public discourse, leading medical organizations maintain that current scientific evidence does not support claims of a proven link between appropriate acetaminophen use during pregnancy and autism.

As always, individuals should speak with a qualified healthcare professional if they have questions about which pain medication is most appropriate for their personal health needs.

FAQs

Is the new Tylenol with naproxen available without a prescription?

Yes. The FDA approved the medication as an over-the-counter product, meaning no prescription is required.

How long does the new medication last?

According to Kenvue, pain relief may last for up to 12 hours.

Does the medication contain opioids?

No. It combines acetaminophen and naproxen sodium, both of which are non-opioid pain relievers.

Can pregnant women take it?

Pregnant individuals should consult their healthcare provider before taking any medication. Medical organizations continue to recommend following professional medical advice regarding acetaminophen use during pregnancy.

Source

• Kenvue official announcement
• U.S. Food and Drug Administration (FDA)
• American College of Obstetricians and Gynecologists (ACOG)

Disclaimer

This article is intended for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. The information in this article is based on publicly available reports and official statements available at the time of writing.